Mesolthelioma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas (NCT01258868) | National Cancer Institute (NCI) | 2010-12-01 |
Track Mesolthelioma automatically
Every clearance here is in the API, with alerts when new ones post.